Cesca Therapeutics Forms Joint Venture With Healthbanks Biotech (USA) To Provide Immune Cell Banking And Cell Processing Services; Joint Venture (ImmuneCyte) Will Initially Be Owned 80% By Healthbanks Biotech And 20% By Cesca
Benzinga Newsdesk